Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-16-126875
Filing Date
2016-06-13
Accepted
2016-06-13 16:54:12
Documents
47
Period of Report
2016-02-29

Document Format Files

Seq Description Document Type Size
1 10-K a16-12117_110k.htm 10-K 923961
2 EX-31.1 a16-12117_1ex31d1.htm EX-31.1 10165
3 EX-31.2 a16-12117_1ex31d2.htm EX-31.2 10111
4 EX-32.1 a16-12117_1ex32d1.htm EX-32.1 5451
5 EX-32.2 a16-12117_1ex32d2.htm EX-32.2 5446
  Complete submission text file 0001104659-16-126875.txt   3049279

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20160229.xml EX-101.INS 428038
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20160229.xsd EX-101.SCH 36442
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20160229_cal.xml EX-101.CAL 25364
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20160229_def.xml EX-101.DEF 93719
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20160229_lab.xml EX-101.LAB 280540
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20160229_pre.xml EX-101.PRE 191884
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

EIN.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-23425 | Film No.: 161711252
SIC: 2835 In Vitro & In Vivo Diagnostic Substances